Preventing Burkholderia cepacia complex infection in cystic fibrosis: Is there a middle ground?

Journal of Pediatrics

Volumn 141, Issue 4, 2002, Pages 467-469

  LiPuma, John J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CHILD; CROSS INFECTION; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DNA FINGERPRINTING; EDITORIAL; HEALTH CARE POLICY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; ORGANIZATION; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SOIL; TREATMENT PLANNING;

EID: 0036798384     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.128892     Document Type: Article

References (27)

1. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990;336:1094-6.
2. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-9.
3. Jones AM, Govan JRW, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 2001;358:557-8.
4. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 2001;358:558-60.
5. Walsh NM, Casano AA, Manangan LP, Sinkowitz-Cochran RL, Jarvis WR. Risk factors for Burkholderia cepacia complex colonization and infection among cystic fibrosis patients. J Pediatr 2002;141:512-7.
6. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bact 1997;47:1188-200.
7. Vandamme P, Mahenthiralingam E, Holmes B, Coenye T, Hoste B, De Vos P, et al. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol 2000; 38:1042-7.
8. Coenye T, LiPuma JJ, Henry D, Hoste B, Mahenthiralingam E, Vandemeulebroecke K, et al. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol 2001;51:271-9.
9. Coenye T, Mahenthiralingam E, Henry D, LiPuma JJ, Laevens S, Gillis M, et al. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex comprising biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 2001;51:1481-90.
10. Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound test results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 2002;33;143-9.
11. LiPuma JJ, Spilker T, Gill L, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility factors in cystic fibrosis. Am J Respir Crit Care Med 2001;164:92-6.
12. Agodi A, Mahenthiralingam E, Bachitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2001;39:2891-6.
13. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002;8:181-7.
14. Johnson WM, Tyler SD, Rozee KR. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994;32:924-30.
15. Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996;44:203-10.
16. Sajjan US, Sun L, Goldstein R, Forstner JF. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995;177:1030-8.
17. Chen JS, Witzmann K, Spilker T, Fink R, LiPuma JJ. Endemicity and intercity spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001;139:643-9.
18. Kumar A, Dietrich S, Schneider W, Jacobson R, Pouch Downes F, Robinson-Dunn BE, et al. Genetic relatedness of Burkholderia (Pseudomonas) cepacia isolates from five cystic fibrosis centers in Michigan. Resp Med 1997;91:485-92.
19. Coenye T, LiPuma JJ. Multilocus restriction typing, a novel tool for studying global, epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Disease 2002;185:1454-62.
20. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-16.
21. Segonds C, Heulin T, Marty N, Chabanon G. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999;37;2201-8.
22. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 2000;38:1763-6.
23. Govan JRW, Balendreau J, Vandamme P. Burkholderia cepacia - friend and foe. ASM News 2000;66:124-5.
24. Balandreau J, Viallard V, Cournoyer B, Coenye T, Laevens S, Vandamme P. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol 2001;67:982-5.
25. LiPuma JJ, Spilker T, Coenye T, Gonzalez CF. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 2002;359:2002-3.
26. Thomassen MJ, Demko CA, Doerschuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis 1986;134:669-71.
27. Blau H, Mussaffi-Georgy H, Fink G, Kaye C, Szeinberg A, Spitzer SA, et al. Effects of an intensive 4-week summer camp on cystic fibrosis: pulmonary function, exercise tolerance, and nutrition. Chest 2002;121:1117-22.